Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Longitude Capital

Longitude Capital?uq=x1rNslWr
VC INVESTOR TYPE
Active STATUS
18 PROFESSIONALS
87 INVESTMENTS
34 PORTFOLIO
39 EXITS
Description

Longitude Capital is a venture capital investment firm that invests in the biotechnology and medical technology sectors. The firm specializes in seed, early stage, later stage, spin-outs, recapitalization, PIPE and structured transactions. It was founded in 2006 and is based in Menlo Park, California with an additional office in Greenwich, Connecticut.

Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
2006
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 2740 Sand Hill Road
  • Suite 200
  • Menlo Park, CA 94025
  • United States

+1 (650) 000-0000

Longitude Capital Investments (87)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Inflazome 19-Nov-2018 Early Stage VC 0000 Drug Discovery Generating Revenue 00000 000000 00.0
00000 25-Oct-2018 00000 00000 0000 Drug Discovery Startup 0000000 00000000 00
0000000 17-Oct-2018 00000 00000 000.00 Drug Discovery Startup 0000000 0000000
00000000000 30-Aug-2018 00000 00000 0000 Elder and Disabled Care Generating Revenue 0000000 00000000 00
00000 000000000000 29-Aug-2018 00000 00000 000.00 Biotechnology Clinical Trials - Phase 2 0000 0000000000 00
00000000 000000000 16-Jul-2018 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 00000 000000 00.0
000000000 00000000 22-May-2018 00000 00000 0000 Drug Discovery Generating Revenue
00000000 19-May-2018 00000 00000 0000 Drug Discovery Pre-Clinical Trials 0000000 0000000
Neurana Pharmaceuticals 03-May-2018 Early Stage VC 0000 Drug Discovery Clinical Trials - General 0000 0000000000 00
Rapid Micro Biosystems 02-May-2018 Later Stage VC 0000 Other Devices and Supplies Generating Revenue 00000 000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Longitude Capital’s full profile, request a free trial.

Longitude Capital Exits (38)

Company Name Exit Date Exit Type Exit Size Status Buyers
Axonics Modulation Technologies 31-Oct-2018 IPO 00000 Completed
0000000000 0000000 06-Aug-2018 0000000000 Completed
  • 00 00000000
0000000 24-Jul-2018 000000000000000000 00000 Completed
  • 0000000 0000000000
0000000 27-Jun-2018 000 00000 Completed
0000000 21-Jun-2018 000 00000 Completed
000000000 00000000 13-Apr-2018 000000000 00000000 Completed
00000000 000000 13-Feb-2018 000000000000000000 00000 Completed
  • 0000000000 0000000
00000000 000000000 25-Sep-2017 000000000000000000 00000 Completed
  • 000000000000
Akebia Therapeutics 14-Aug-2017 Public Investment 2nd Offering Completed
Kala Pharmaceuticals 20-Jul-2017 IPO 0000 Completed
To view this investor’s complete exits history, request access »

Longitude Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore Longitude Capital‘s full profile, request access.

Request full access to PitchBook

Longitude Capital Team (34)

Name Title Deals Funds Boards Office Contact
Info
Carolyn Helms Chief Financial Officer & Chief Compliance Officer Menlo Park, CA
Juliet Bakker Co-Founder, Chief Executive Officer & Managing Director 00 0 0 Greenwich, CT
David Hirsch Ph.D Co-Founder & Managing Director 00 0 0 Greenwich, CT
Marc-Henri Galletti Co-Founder & Managing Director 0 0 0 Menlo Park, CA
Gregory Grunberg MD Managing Director 00 0 0 Menlo Park, CA

14 Former Team Members

You’re viewing 5 of 34 team members. Get the full list »

Longitude Capital Co-Investors (131)

Name With Exits Lead Partner
OrbiMed 7 0 0
RA Capital Management 0 0 0
Adage Capital Management 0 0 0
Fountain Healthcare Partners 0 0 0
Frazier Healthcare Partners 0 0 0
To view this investor’s complete co-investor history, request access »